NZ HIV Medicine Research Review Issue 21

In this issue:
Lopinavir-ritonavir: adrenal dysfunction in newborns
Antiretroviral therapy and TB risk
Abacavir vs tenofovir regimens for initial therapy
Zidovudine-sparing HAART in pregnancy
Fertility intentions of HIV-infected women
Nevirapine vs atazanavir/ritonavir: CV risks compared
Abacavir and CV risk
PI-based HAART: increased preterm delivery
Once-daily vs twice-daily nevirapine formulations
Target screening for TB before HAART initiation

Please login below to download this issue (PDF)